These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 2931901)

  • 21. Further experience with chemotherapy in the Dunning prostatic adenocarcinoma.
    Block NL; Camuzzi F; Stover B; Claflin A; Troner M; Politano VA
    Trans Am Assoc Genitourin Surg; 1978; 70():57-9. PubMed ID: 753023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of chemotherapy in the treatment of lung cancer.
    Selawry OS
    Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone].
    Raevskiĭ IG
    Sov Med; 1976 Aug; (8):112-4. PubMed ID: 1006408
    [No Abstract]   [Full Text] [Related]  

  • 24. [Recent personal results in advanced bronchial cancer. Palliative immuno-chemotherapy. 63 cases].
    Israel L; Depierre A
    Ann Med Interne (Paris); 1976 Jan; 127(1):39-42. PubMed ID: 64125
    [No Abstract]   [Full Text] [Related]  

  • 25. Experiences with estramustine phosphate (Estracyt, Emcyt) in prostate cancer.
    Murphy GP; Slack NH; Mittelman A
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):34-42. PubMed ID: 6364365
    [No Abstract]   [Full Text] [Related]  

  • 26. [Indication and achievements of after-care examinations of urologic tumors. Chemotherapeutic report].
    Kühböck J
    Fortschr Geb Rontgenstr Nuklearmed; 1973; 0(0):suppl:157-60. PubMed ID: 4135300
    [No Abstract]   [Full Text] [Related]  

  • 27. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy of hormone-resistant carcinoma of the prostate: 4-epi-rubicin weekly v.s. DMF monthly.
    Burk K; Sropp C; Schultze-Seemann W; de Riese W
    Prog Clin Biol Res; 1987; 243B():243-6. PubMed ID: 3116556
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advanced cancer of the prostate: chemotherapy].
    Garcia-Giralt E; Palangie T; Dorval T; Jouve M; Pouillart P
    Bull Cancer; 1986; 73(1):68-73. PubMed ID: 3779125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy of gastrointestinal cancer.
    Regelson W
    Int J Radiat Oncol Biol Phys; 1975; 1(1-2):109-17. PubMed ID: 61195
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antiblastic chemotherapy in esophageal cancer].
    Cartei G
    Radiol Med; 1983; 69(7-8):597-600. PubMed ID: 6322245
    [No Abstract]   [Full Text] [Related]  

  • 33. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
    Lopez M
    Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
    [No Abstract]   [Full Text] [Related]  

  • 34. [Combination cytostatic chemotherapy of advanced metastatic cancer of the prostate. A preliminary uncontrolled study].
    Ogaard S; Jensen TS
    Ugeskr Laeger; 1977 Feb; 139(9):515-7. PubMed ID: 841743
    [No Abstract]   [Full Text] [Related]  

  • 35. The chemotherapy of advanced bladder carcinoma.
    deKernion JB
    Cancer Res; 1977 Aug; 37(8 Pt 2):2771-4. PubMed ID: 326391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy studies in an animal tumor spectrum. II. Sensitivity of tumors to fourteen antitumor chemicals.
    Tarnowski GS; Schmid FA; Cappuccino JG; Stock CC
    Cancer Res; 1966 Mar; 26(3 Pt 2):181-206. PubMed ID: 4223040
    [No Abstract]   [Full Text] [Related]  

  • 37. Update in cancer chemotherapy, Part III: Lung cancer, Part 1.
    Wright JC
    J Natl Med Assoc; 1985 Oct; 77(10):815-27. PubMed ID: 2414458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
    Al-Ali HK; Wittekind C; Niederwieser D
    Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of mathematical modeling in protocol formulation in cancer chemotherapy.
    Coldman AJ; Goldie JH
    Cancer Treat Rep; 1985 Oct; 69(10):1041-8. PubMed ID: 2412691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of chemotherapy of soft tissue sarcoma in adults].
    Santoro A; Viviani S
    Radiol Med; 1984 Nov; 70(11):893-5. PubMed ID: 6399763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.